GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diva Laboratories Ltd (ROCO:4153) » Definitions » Interest Expense

Diva Laboratories (ROCO:4153) Interest Expense : NT$-0.2 Mil (TTM As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Diva Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Diva Laboratories's interest expense for the three months ended in Mar. 2025 was NT$ -0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-0.2 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Diva Laboratories's Operating Income for the three months ended in Mar. 2025 was NT$ 30.5 Mil. Diva Laboratories's Interest Expense for the three months ended in Mar. 2025 was NT$ -0.0 Mil. Diva Laboratories's Interest Coverage for the quarter that ended in Mar. 2025 was 1,220.72. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Diva Laboratories Interest Expense Historical Data

The historical data trend for Diva Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diva Laboratories Interest Expense Chart

Diva Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.11 -0.20 -0.33 -0.21

Diva Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.11 -0.03 -0.03 -0.03

Diva Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diva Laboratories  (ROCO:4153) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Diva Laboratories's Interest Expense for the three months ended in Mar. 2025 was NT$-0.0 Mil. Its Operating Income for the three months ended in Mar. 2025 was NT$30.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was NT$2.3 Mil.

Diva Laboratories's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2025 )/Interest Expense (Q: Mar. 2025 )
=-1*30.518/-0.025
=1,220.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Diva Laboratories Ltd has enough cash to cover all of its debt. Its financial situation is stable.


Diva Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Zhongshan Road, 9F, No. 351, Sector 2, Zhonghe District, New Taipei City, TWN, 235
Diva Laboratories Ltd is a Taiwan-based company that engages in the sale, manufacturing, and development of medical equipment and computer-related devices. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.

Diva Laboratories Headlines

No Headlines